Cell cycle and immune-related processes are significantly altered in chronic GVHD

Area of Science:

• Immunology
• Genomics
• Molecular Biology

Background:

• The precise mechanisms driving chronic graft-versus-host disease (GVHD) remain largely unknown.
• Understanding the molecular underpinnings of chronic GVHD is crucial for improving patient outcomes following allogeneic hematopoietic stem cell transplantation (HSCT).

Purpose of the Study:

• To investigate the molecular characteristics and identify differentially expressed genes and pathways associated with chronic GVHD.
• To develop a gene-based classifier for predicting chronic GVHD status in HSCT recipients.

Main Methods:

• Gene expression profiling was performed on mononuclear cells from 21 HSCT recipients (chronic GVHD vs. non-GVHD).
• Analysis included Self-Organizing Map (SOM) clustering, Significance Analysis of Microarray (SAM), Gene Ontology (GO) annotation, quantitative real-time PCR (qRT-PCR), and Prediction Analysis of Microarray (PAM).

Main Results:

• Distinct gene expression profiles differentiated chronic GVHD from non-GVHD samples.
• 120 genes were upregulated (e.g., PTDSS1, VAV1, CD3D) and 5 downregulated (e.g., calnexin) in GVHD patients, linked to phosphorous metabolism and lipid biosynthesis.
• Differential expression was significant in cell cycle and T cell immune pathways; a 17-gene classifier achieved 85% prediction accuracy for chronic GVHD.

Conclusions:

• Microarray analysis successfully identified key differentially expressed genes and biological pathways in chronic GVHD.
• Diagnostic gene signatures were established, offering potential for predicting chronic GVHD status in HSCT patients.